What do we think about selective estrogen receptor modulators (SERMS)?

被引：0

作者：

Cortet, B ^{[1
]}

机构：

[1] Ctr Hosp Reg & Univ Lille, Hop Roger Salengro, Serv Rhumatol, F-59037 Lille, France

来源：

REVUE DE MEDECINE INTERNE | 2001年 / 22卷 / 12期

关键词：

selective estrogen receptor modulator (SERMs) hormone replacement therapy; osteoporosis; breast cancer;

D O I：

10.1016/S0248-8663(01)00487-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1173 / 1176

页数：4

共 12 条

[1]

Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0

[2] Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial [J].

Cauley, JA ;

Norton, L ;

Lippman, ME ;

Eckert, S ;

Krueger, KA ;

Purdie, DW ;

Farrerons, J ;

Karasik, A ;

Mellstrom, D ;

Ng, KW ;

Stepan, JJ ;

Powles, TJ ;

Morrow, M ;

Costa, A ;

Silfen, SL ;

Walls, EL ;

Schmitt, H ;

Muchmore, DB ;

Jordan, VC .

BREAST CANCER RESEARCH AND TREATMENT, 2001, 65 (02) :125-134

[3] Estrogens still and always? [J].

Cortet, B ;

Roux, C .

REVUE DE MEDECINE INTERNE, 2000, 21 (05) :401-404

[4] The effect of raloxifene on risk of breast cancer in postmenopausal women - Results from the MORE randomized trial [J].

Cummings, SR ;

Eckert, S ;

Krueger, KA ;

Grady, D ;

Powles, TJ ;

Cauley, JA ;

Norton, L ;

Nickelsen, T ;

Bjarnason, NH ;

Morrow, M ;

Lippman, ME ;

Black, D ;

Glusman, JE ;

Costa, A ;

Jordan, VC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (23) :2189-2197

[5] Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women [J].

Delmas, PD ;

Bjarnason, NH ;

Mitlak, BH ;

Ravoux, AC ;

Shah, AS ;

Huster, WJ ;

Draper, M ;

Christiansen, C .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (23) :1641-1647

[6] Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene -: Results from a 3-year randomized clinical trial [J].

Ettinger, B ;

Black, DM ;

Mitlak, BH ;

Knickerbocker, RK ;

Nickelsen, T ;

Genant, HK ;

Christiansen, C ;

Delmas, PD ;

Zanchetta, JR ;

Stakkestad, J ;

Glüer, CC ;

Krueger, K ;

Cohen, FJ ;

Eckert, S ;

Ensrud, KE ;

Avioli, LV ;

Lips, P ;

Cummings, SR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07) :637-645

[7] Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].

Fisher, B ;

Costantino, JP ;

Wickerham, DL ;

Redmond, CK ;

Kavanah, M ;

Cronin, WM ;

Vogel, V ;

Robidoux, A ;

Dimitrov, N ;

Atkins, J ;

Daly, M ;

Wieand, S ;

Tan-Chiu, E ;

Ford, L ;

Wolmark, N .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388

[8] Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women [J].

Hulley, S ;

Grady, D ;

Bush, T ;

Furberg, C ;

Herrington, D ;

Riggs, B ;

Vittinghoff, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (07) :605-613

[9] EFFECTS OF TAMOXIFEN ON UTERUS AND OVARIES OF POSTMENOPAUSAL WOMEN IN A RANDOMIZED BREAST-CANCER PREVENTION TRIAL [J].

KEDAR, RP ;

BOURNE, TH ;

POWLES, TJ ;

COLLINS, WP ;

ASHLEY, SE ;

COSGROVE, DO ;

CAMPBELL, S .

LANCET, 1994, 343 (8909) :1318-1321

[10] EFFECTS OF TAMOXIFEN ON BONE-MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER [J].

LOVE, RR ;

MAZESS, RB ;

BARDEN, HS ;

EPSTEIN, S ;

NEWCOMB, PA ;

JORDAN, VC ;

CARBONE, PP ;

DEMETS, DL .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (13) :852-856

← 1 2 →